Viewing Study NCT06374394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-01-06 @ 9:19 PM
Study NCT ID: NCT06374394
Status: COMPLETED
Last Update Posted: 2025-05-23
First Post: 2024-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Syncytial Virus Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RSV View
None Respiratory Syncytial Virus View
None COVID-19 mRNA vaccine View
None Immunogenicity View
None Safety View
None Reactogenicity View
None Older Adults View